<DOC>
	<DOCNO>NCT02729558</DOCNO>
	<brief_summary>Objective : To improve local control follow complete resection single brain metastasis use fractionated local stereotactic radiotherapy , whilst maintain neurological functioning , neurocognition quality life . Study design : Multicenter randomize phase III , least three high-volume Dutch center participate trial . Stratification primary tumor type age . Study population : Patients undergo complete resection single brain metastasis , confirm early ( i.e . within 72 hour ) postoperative contrast-enhanced MR scan . Study intervention : Patients randomized observation alone ( standard arm ) local stereotactic radiotherapy three fraction 8 Gy surgical cavity ( study arm ) . Main study parameter : Primary objective : local control rate 6 month . Secondary objective : local control rate 12 month , neurological functioning , freedom clinical neurological progression , performance status , quality life , toxicity , steroid use , neurocognition overall survival .</brief_summary>
	<brief_title>Local Radiotherapy Following Complete Resection Brain Metastasis</brief_title>
	<detailed_description>The objective study improve local control follow complete resection single brain metastasis solid tumor use fractionated local stereotactic radiotherapy , whilst maintain neurological functioning , neurocognition quality life . The study perform form multicenter randomize phase III , least three high-volume Dutch center participate trial . Stratification perform primary tumor type age . A total 70 patient include . Inclusion restrict patient underwent complete resection single brain metastasis , confirm early ( i.e . within 72 hour ) postoperative contrast-enhanced magnetic resonance ( MR ) scan . Patients randomized observation alone ( standard arm ) local stereotactic radiotherapy three fraction 8 Gy surgical cavity ( study arm ) .The main study parameter : local control rate 6 month ( primary outcome measure ) local control rate 12 month , neurological functioning , freedom clinical neurological progression , performance status , quality life , toxicity , steroid use , neurocognition overall survival ( secondary outcome measure ) . Follow perform three-monthly interval first two year , include MRI scan . Quality life questionaires neurocognitive functioning test perform fixed interval follow-up .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Age 18 year old . Radiologically confirm complete resection single brain metastasis contrastenhanced MRI within 72 h resection . Primary solid tumor , exclude hematologic malignancy , germ cell tumor , small cell lung cancer . Stable extracranial tumor ( primary tumor and/or systemic metastasis ) last three month without treatment progressive extracranial tumor and/or systemic metastasis effective treatment available . World Health Organization ( WHO ) performance score 02 . Ability provide write informed consent . Prior treatment brain metastasis ( i.e . surgery , stereotactic radiotherapy WBRT ) . Distant brain metastasis radiological finding MRI suspect leptomeningeal tumor spread postoperative MRI . Concurrent use systemic therapy local stereotactic radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>brain metastasis</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>resection</keyword>
</DOC>